A Tokyo hospital says at least 57 people contracted hepatitis C after undergoing heart surgery, during which a surgical tissue adhesive made from an HCV-contaminated fibrinogen blood product was used. The glue in question is suspected to have been used on about 79,000 patients between 1981 and 1987.

Related Summaries